Aripiprazole Impurity 41

Basic Information

View in Editor

CAS Number

203395-59-9

Molecular Formula

C13H14BrNO2

Molecular Weight

296.16 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Agricultural Chemicals Pesticides Herbicides

Basic Physical Properties

Melting Point

126-128 ºC

Boiling Point

475.3°C at 760 mmHg

SMILES

View in Editor

C1=CC(=CC2=C1C=CC(=O)N2)OCCCCBr

InChI

InChI=1S/C13H14BrNO2/c14-7-1-2-8-17-11-5-3-10-4-6-13(16)15-12(10)9-11/h3-6,9H,1-2,7-8H2,(H,15,16)

InChIKey

MBOHAVAGDOGRBS-UHFFFAOYSA-N

LogP

3.0820000000000016

Topological Polar Surface Area

42.09 Å²

Hydrogen Bond Donor/Acceptor

1 / 3

Complexity

293

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

7-(4-Bromobutoxy)-quinoline-2(1H)-one
7-(4-bromobutoxy)-1H-quinolin-2-one
7-(4-bromobutoxy)-2(1H)-Quinolinone
7-(4-Bromobutoxy)quinolin-2(1H)-one
AK319334
7-(4-bromobutoxy)quinolinone
MBOHAVAGDOGRBS-UHFFFAOYSA-N
9380AF
7-(4-Bromobutoxy)quinoline-2(1H)-one
SY105851
AS-10671
DA-35886
203395-59-9
PD133218
7-(4-Bromobutoxy)-2(1H)-quinolinone; 7-(4-Bromobutoxy)quinolin-2(1H)-one
MFCD09753615
DTXSID00444506
SCHEMBL251608
A920781
AKOS027325279
SB71451
7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE
CS-0187242
D70783
7-(4-bromobutoxy)quinolin-2(1H)-one

MDL Number

MFCD09753615

FAQ

What regulatory guidelines apply to Aripiprazole Impurity 41 (CAS: 203395-59-9)?

Aripiprazole Impurity 41 (CAS: 203395-59-9) must comply with regulatory guidelines such as REACH in the EU, which requires registration, evaluation, authorization, and restriction of chemical substances. Additionally, it should adhere to OSHA standards in the USA and similar occupational health and safety regulations in other countries. FDA and EPA requirements also apply, particularly for environmental and safety handling during synthesis and disposal.

Are there alternatives to Aripiprazole Impurity 41 (CAS: 203395-59-9) in synthesis?

Alternatives to Aripiprazole Impurity 41 (CAS: 203395-59-9) may include similar impurities from other central nervous system drugs or different impurities from the same drug. Common substitutes in synthesis could be other aripiprazole analogs or isomers. For example, impurities like Aripiprazole Impurity 40 or 42 might be considered as alternatives based on their structural similarity.

What is the market or research trend for Aripiprazole Impurity 41 (CAS: 203395-59-9)?

Market trends for Aripiprazole Impurity 41 (CAS: 203395-59-9) are linked with the broader market for antipsychotic drugs, particularly aripiprazole. Research is focusing on the development of more effective and safer impurities, which could lead to improved drug formulations. Additionally, environmental concerns are driving research on safer waste disposal methods and more sustainable synthesis processes.

How should waste containing Aripiprazole Impurity 41 (CAS: 203395-59-9) be handled?

Waste containing Aripiprazole Impurity 41 (CAS: 203395-59-9) should be collected and handled in accordance with local and international hazardous waste regulations. Hazardous waste disposal should be conducted by a licensed professional facility. Environmental protection measures include ensuring no hazardous substances enter the water or soil, and proper incineration or chemical treatment to reduce the risk of environmental contamination.